Singapore eDev - COVID-19 in Play

2020 are COVID-19 plays, any penny health stocks that have some news of success on COVID-19 can suddenly POWER UP.    Don't be the last one holdings such stocks as many are overprice due to the hype.

Impact Biomedical Achieves COVID-19 Success with Equivir and 3F Biofragrance

SINGAPORE, June 24, 2020 - (ACN Newswire) - Singapore eDevelopment Limited's (SeD; SGX:40V) wholly owned subsidiary Impact Biomedical Inc. has announced proven in vitro success with Equivir and 3F Biofragrance against COVID-19 in independent laboratory testing. Impact Biomedical and Global Research and Discovery Group Sciences (GRDG), in independent Biosafety Level 3 containment facilities, challenged its compounds with the SARS-CoV-2 virus. Equivir proved successful as a treatment, as well as a prophylactic protecting the cells from infection by the virus. Currently, there are no COVID-19 prophylactics.

Rule number 1: Always put a stop loss before entry, always, no exception. You do not drive a car if it does not have brakes. Have a stop loss first, then think about entry, end of conversation.

Rule number 2:: No Rule number 2, strictly master Rule Number 1 and you are likely to succeed in Technical Trading.